The prothrombotic potential of platelet factor 4

European Journal of Internal Medicine

Volumn 21, Issue 2, 2010, Pages 79-83

  Thachil, Jecko ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Heparin; Monocyte; Platelet; Thrombocytopenia; Thrombosis

Indexed keywords

ENOXAPARIN; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE SULFATE; THROMBIN INHIBITOR; THROMBOCYTE FACTOR 4;

HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LABORATORY TEST; NONHUMAN; PATHOGENESIS; REVIEW; SEROPREVALENCE; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; THROMBOSIS;

CHEMOTAXIS, LEUKOCYTE; HEPARIN; HUMANS; MONOCYTES; PLATELET ACTIVATION; PLATELET FACTOR 4; THROMBOCYTOPENIA; THROMBOSIS;

EID: 77549083170     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.11.007     Document Type: Review

References (37)

1. Warkentin T.E. Heparin-induced thrombocytopenia. Hematol Oncol Clin North Am 21 (2007) 589-607
2. Warkentin T.E., Makris M., Jay R.M., and Kelton J.G. A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia. Am J Med 121 (2008) 632-636
3. Matsuo T., Suzuki S., Matsuo M., and Kobayasi H. Preexisting antibodies to platelet factor 4-heparin complexes in patients with acute coronary syndrome who have no history of heparin exposure. Pathophysiol Haemost Thromb 34 (2005) 18-22
4. Martin-Toutain I., Piette J.C., Diemert M.C., Faucher C., Jobic L., and Ankri A. High prevalence of antibodies to platelet factor 4 heparin in patients with antiphospholipid antibodies in absence of heparin-induced thrombocytopenia. Lupus 16 (2007) 79-83
5. Arepally G.M., and Hursting M.J. Platelet factor 4/heparin antibody (IgG/M/A) in healthy subjects: a literature analysis of commercial immunoassay results. J Thromb Thrombolysis 26 (2008) 55-61
6. Holt J.C., and Niewiarowski S. Biochemistry of alpha granule proteins. Semin Hematol 22 (1985) 151-163
7. Lane D.A., Ireland H., Wolff S., Ranasinghe E., and Dawes J. Detection of enhanced in vivo platelet alpha-granule release in different patient groups: comparison of beta thromboglobulin, platelet factor 4 and thrombospondin assays. Thromb Haemost 52 (1984) 183-187
8. Eslin D.E., Zhang C., Samuels K.J., Rauova L., Zhai L., Niewiarowski S., et al. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood 104 (2004) 3173-3180
9. Deuel T.F., Senior R.M., Chang D., Griffin G.L., Heinrikson R.L., and Kaiser E.T. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA 78 (1981) 4584-4587
10. Lambert M.P., Sachais B.S., and Kowalska M.A. Chemokines and thrombogenicity. Thromb Haemost 97 (2007) 722-729
11. Chesterman C.N., McGready J.R., Doyle D.J., and Morgan F.J. Plasma levels of platelet factor 4 measured by radioimmunoassay. Br J Haematol 40 (1978) 489-500
12. Parratt R., and Hunt B.J. Direct activation of factor X by monocytes occurs during cardio-pulmonary bypass. Br J Haematol 101 (1998) 40-46
13. Pouplard C., Iochmann S., Renard B., Herault O., Colombat P., Amiral J., et al. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood 97 (2001) 3300-3302
14. Arepally G.M., and Mayer I.M. Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8. Blood 98 (2001) 1252-1254
15. van Gils J.M., Zwaginga J.J., and Hordijk P.L. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol. 85 (2009) 195-204
16. Shanberge J.N., and Quattrociocchi-Longe T.M. Influence of platelet factor 4 on the neutralization of heparin by protamine. Ann NY Acad Sci 556 (1989) 354-365
17. Amelot A.A., Tagzirt M., Libraire J., and Le Bonniec B.F. Platelet factor 4 (CXCL4) shields plasma factor V to thrombin and retards activation. J Thromb Haemost 5 supp2 (2007) abstract number PP-MO-237
18. Yang L., and Rezaie A.R. Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors. Thromb Haemost 97 (2007) 899-906
19. Slungaard A., Fernandez J.A., Griffin J.H., Key N.S., Long J.R., Piegors D.J., et al. Platelet factor 4 enhances generation of activated protein C in vitro and in vivo. Blood 102 (2003) 146-151
20. Han Z.C., Sensébe L., Abgrall J.F., and Brière J. Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood 75 (1990) 1234-1239
21. Hrushesky W.J. Subcutaneous heparin-induced thrombocytopenia. Arch Intern Med 138 (1978) 1489-1491
22. Wahl T.O., Lipschitz D.A., and Stechschulte D.J. Thrombocytopenia associated with antiheparin antibody. JAMA 240 (1978) 2560-2562
23. Houwerzijl E.J., Blom N.R., van der Want J.J., Vellenga E., and de Wolf J.T. Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death. Leukemia 20 (2006) 1937-1942
24. Lambert M.P., Wang Y., Bdeir K.H., Nguyen Y., Kowalska M.A., and Poncz M. Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor-related protein 1 (LRP1) on megakaryocytes. Blood 114 (2009) 2290-2298
25. Fausett M.B., Vogtlander M., Lee R.M., Esplin M.S., Branch D.W., Rodgers G.M., et al. Heparin-induced thrombocytopenia is rare in pregnancy. Am J Obstet Gynecol 1 (2001) 148-152
26. Hong A.P., Cook D.J., Sigouin C.S., and Warkentin T.E. Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia. Blood 101 (2003) 3049-3051
27. Pitsilos S., Hunt J., Mohler E.R., Prabhakar A.M., Poncz M., Dawicki J., et al. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost 90 (2003) 1112-1120
28. Woller G., Brandt E., Mittelstädt J., Rybakowski C., and Petersen F. Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals. J Leukoc Biol 83 (2008) 936-945
29. Harding S.A., Din J.N., Sarma J., Josephs D.H., Fox K.A., and Newby D.E. Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparin. Heart 92 (2006) 1635-1638
30. Cines D.B., Rauova L., Arepally G., Reilly M.P., McKenzie S.E., Sachais B.S., et al. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly. J Clin Apher 22 (2007) 31-36
31. Ziporen L., Li Z.Q., Park K.S., Sabnekar P., Liu W.Y., Arepally G., et al. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia. Blood 92 (1998) 3250-3259
32. Visentin G.P., Moghaddam M., Beery S.E., McFarland J.G., and Aster R.H. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis. J Lab Clin Med 138 (2001) 22-31
33. Prechel M.M., McDonald M.K., Jeske W.J., Messmore H.L., and Walenga J.M. Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin. J Thromb Haemost 3 (2005) 2168-2175
34. Socher I., Kroll H., Jorks S., Santoso S., and Sachs U.J. Heparin-independent activation of platelets by heparin-induced thrombocytopenia antibodies: a common occurrence. J Thromb Haemost 6 (2008) 197-200
35. Bauer T.L., Arepally G., Konkle B.A., Mestichelli B., Shapiro S.S., Cines D.B., et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass. Circulation 95 (1997) 1242-1246
36. Ernofsson M., Thelin S., and Siegbahn A. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg 113 (1997) 576-584
37. Khan M.M., Gikakis N., Miyamoto S., Rao A.K., Cooper S.L., Edmunds Jr. L.H., et al. Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardio-pulmonary bypass. Ann Thorac Surg 68 (1999) 473-478